Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The Gym Group saw 8% revenue growth in 2025, boosted by demand from weight-loss drug users, and plans 75 new gyms.
The Gym Group reports strong financial growth in 2025, with 8% revenue rise to £244.9 million and membership up 4% to 923,000, driven by increased demand from users of weight-loss drugs like Mounjaro and Wegovy.
CEO Will Orr cites these medications as a "tailwind," boosting gym visits as people seek to maintain muscle and sustain results.
The company plans to open 75 new gyms over the next three years—25 more than before—and launched a £10 million share buyback.
Analysts view the performance positively, citing growth momentum and strong Gen Z engagement.
Full-year results are due March 11.
9 Articles
El Grupo Gym registró un crecimiento de ingresos del 8% en 2025, impulsado por la demanda de usuarios de drogas para bajar de peso, y planea 75 nuevos gimnasios.